Environmental exposure to thousands of synthetic chemicals poses a growing challenge for public health, largely because their ...

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) (“Cyclerion” or "Company”), a biopharmaceutical company pioneering neuropsychiatric therapies, today announced it has received positive written regulatory ...

Sunshine Metals Ltd (ASX:SHN) has outlined a potential pathway to production at its Liontown deposit in North Queensland, ...

Deep learning is increasingly used in financial modeling, but its lack of transparency raises risks. Using the well-known Heston option pricing model as a benchmark, researchers show that global ...

Cinematographer Dale Campbell explains how Blackmagic's PYXIS 12K camera helped create a sharp and cinematic finish for TWG ...

The main take-home message is that regulatory approval doesn't mean a device works. It means it's safe,” according to Katya ...

Kratos looks different in God of War: Sons of Sparta, but the backlash may say more about fan expectation than the design ...

Jack Lundin, President and CEO of Lundin Mining, commented, "The publication of these impressive results marks a significant ...

Layered transition-metal oxides are among the most promising cathode materials for sodium-ion batteries because of their high theoretical capacity and low cost. However, conventional designs rely on ...

Disc Medicine stock is hit by an FDA CRL for bitopertin. Learn key trial risks, cash runway, and why APOLLO Phase 3 results ...

The FDA’s refusal to review Moderna’s mRNA-based flu vaccine is part of a larger communications crisis unfolding at the agency over the past nine months that has also ensnarled Sarepta, Capricor, ...

Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 12:30 PM ESTCompany ParticipantsR.